Explorer les evidences

41,6 %41.6% (252/606) of the discharged patients had one or more comorbidities.

Nigeriacomorbiditiespublié 2023Nigerian journal of clinical practicePubMeddocument de 6 observations

13,9 %Among children diagnosed with cerebral palsy, 54 (13.9%) were classified as Gross Motor Function Classification System level III.

Nigeriacerebral palsypublié 2020Archives of disease in childhoodPubMeddocument de 27 observations

Characterizing tumors for homologous recombination deficiency has significant clinical relevance in stratifying patients for potentially life-saving therapies.

Nigeriacancer du seinpublié 2021Nature communicationseurope_pmcdocument de 3 observationsDOI 10.1038/s41467-021-27079-w

2,42 mg/LSerum high-sensitivity C-reactive protein (hsCRP) levels were higher in moderate-to-high CVD risk individuals (median: 2.42 mg/L) compared to lower-risk individuals (median: 1.22 mg/L).

Nigeriamaladies cardiovasculairespublié 2025BMC cardiovascular disordersPubMeddocument de 3 observations

95,2 %Plasmodium falciparum was seen in 95.2% of the malaria cases as either mixed infection with P. malariae (3.6%) or as a mono infection (91.6%).

Nigeriapaludismepublié 2013Infectious diseases of povertyeurope_pmcdocument de 6 observationsDOI 10.1186/2049-9957-2-19

54 %Fifty-four percent of adult females in Nigeria are centrally obese.

Nigeriacentral obesitypublié 2022Public healthPubMeddocument de 7 observations

82 %In Nigeria, 82% of pregnant women received HIV/PMTCT counsel during antenatal care.

NigeriaVIH/sidaobservé 2018publié 2023BMC health services researchPubMeddocument de 13 observations

100 %The cure rate was 100% on days 14 and 28 with mefloquine.

Nigeriapaludismepublié 1997Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument de 6 observations

4,4 %The prevalence of HCV infection among HIV-infected people in Port Harcourt, Rivers State was 4.4%.

Nigeriahépatite C · VIH/sidapublié 2021African health sciencesPubMeddocument de 4 observations

5,88 %Neonatal cord blood parasitaemia prevalence was 5.88% among women who took sulfadoxine-pyrimethamine twice.

Nigeriapaludismepublié 2022African health sciencesPubMeddocument de 22 observations

17,4 %Of the tuberculosis cases reviewed, 17.4% defaulted treatment.

Nigeriatuberculoseobservé 2008 to 2014publié 2020Journal of infection and public healthPubMeddocument de 16 observations

99,2 %Among SCD patients, 130 (99.2%) were extensive metabolizers and 1 (0.8%) was a poor metabolizer of proguanil.

Nigeriadrépanocytosepublié 2016Pharmacology research & perspectiveseurope_pmcdocument de 5 observations

18,5 %Children aged 6–12 years exhibited a malaria and typhoid co-infection rate of 18.5%.

Nigeriamalaria and typhoid feverpublié 2024Malaria journalPubMeddocument de 7 observations

0,49 ORRelative to Phase-2, knowledge changes at Phase-4 for questions associated with the myth 'enemy poisons' were reversed, with an odds ratio of 0.49 (95% CI: 0.37–0.65).

Nigeriacancer du col de l'utéruspublié 2022BMC public healthPubMeddocument de 13 observations

48,9 %ECG abnormalities were recorded in 22 out of 45 (48.9%) pediatric sickle cell anaemia patients in steady state.

Nigeriadrépanocytoseobservé 2023publié 2025BMC pediatricsPubMeddocument de 16 observations

23,8 %Severity of fungal dermatoses was significantly lower in the HAART-experienced group, with 23.8% having severe infection.

Nigeriafungal dermatosespublié 2026Nigerian journal of clinical practicePubMeddocument de 6 observations

No significant association was observed between BRCA1 variants rs799917 and rs1799966 and breast cancer risk in the Nigerian cohort.

Nigeriacancer du seinpublié 2026Cancer control : journal of the Moffitt Cancer CenterPubMeddocument de 7 observations

97,8 %Retention rate at 12 months was 97.8% among adults enrolled in differentiated service delivery models compared to 96.7% among children, with a p-value of 0.04.

NigeriaVIH/sidapublié 2021Journal of the International AIDS SocietyPubMeddocument de 6 observations

5,7 %Overall, mean deficit in haematocrit from baseline (DIHFB) was 5.7% 7 days after treatment initiation in children with malaria treated with artemisinin-based combination treatments.

Nigeriapaludismepublié 2019Parasite (Paris, France)europe_pmcdocument de 5 observationsDOI 10.1051/parasite/2019058

3,22 USDThe programmatic economic cost of delivering an insecticide-treated net (ITN) to a household was estimated at $3.22 in Ondo State, Nigeria.

Nigeriapaludismepublié 2026Malaria journalPubMeddocument de 10 observations

93,5 %43 (93.5%) RBM focal persons in Benue State found it easy to fill the standardized malaria data tools.

Nigeriapaludismepublié 2022Malaria journalPubMeddocument de 10 observations

1,7 odds_ratioIn adjusted analyses, microscopy detectable gametocytemia at enrolment was associated with an increase in the odds of IgG seropositivity to Pf s230D1M (OR 1.70 [95% CI 1.03, 2.80], p = 0.037).

Nigeriapaludismepublié 2022Frontiers in cellular and infection microbiologyeurope_pmcdocument de 7 observations

There was a significant prolongation in both the prothrombin time and activated partial thromboplastin time among the malaria parasitized pregnant subjects compared to the non-parasitized controls (p = 0.000).

Nigeriapaludismepublié 2020Human antibodiesPubMeddocument de 2 observations

0,4 %Immune escape HBV variants were detected in 0.4% of cases.

Nigeriahépatite Bobservé 2018publié 2025Pathogens (Basel, Switzerland)PubMeddocument de 8 observations

6 countriesAs of 05 September 2024, six countries were experiencing sustained human-to-human mpox transmission: the Democratic Republic of the Congo, Burundi, Nigeria, South Africa, Cote d’Ivoire, and the Central African Republic.

Afrique du Sud · Burundi · Nigeria · RDCmpoxobservé 05 September 2024Africa CDCdocument de 48 observations